Market closed
Access this stock data via API
Subscribe
Giant Biogene Holding Co. Ltd.
0
0
0%

Financials

Income statement

Fundamentals currency is CNY
Fiscal date 2024 2023 2022 2021
Total reported revenue 6.1B 3.9B 2.6B 1.6B
Cost of revenue 1.1B 636.9M 403.2M 198.1M
Gross profit 5.0B 3.3B 2.2B 1.4B
Operating expense
Research & development 117.6M 82.7M 48.1M 25.0M
Selling general and admin 2.4B 1.4B 892.7M 418.5M
Other operating expenses 768.8K 4.5M
Operating income 2.5B 1.8B 1.3B 931.7M
Non operating interest income
Income 122.9M 52.4M 14.4M 9.4M
Expense 263.8K 123.6K 22.9K 0
Other income expense
Pretax income 2.7B 1.9B 1.3B 972.9M
Tax provision 437.1M 327.7M 192.4M 144.8M
Net income 2.3B 1.6B 1.1B 828.1M
Basic EPS 2.1 1.5 1.0 0.8
Diluted EPS 2.1 1.5 1.0 0.8
Basic average shares 1.1B 1.1B 767.9M 929.3M
Diluted average shares 1.1B 1.1B 767.9M 929.3M
EBITDA 2.7B 1.9B 1.3B 983.0M
Net income from continuing op. 2.7B 1.9B 1.3B 972.9M
Minority interests 620K 3.6M 439K 0
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 1 hour 17 minutes

07:42
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
09:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 16:10
All times are displayed in the Asia/Hong_Kong timezone (HKT, UTC+08:00).